THE CHALLENGES AND SPECIFICITIES OF THE PHARMACOVIGILANCE OF ANTIVENOMS

被引:0
|
作者
Soria, Raul [1 ]
Vazquez, Fernando [1 ]
机构
[1] INOSAN BIOPHARMA, Mexico City, DF, Mexico
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [1] Pharmacovigilance of Antivenoms in Toxicological Emergencies
    Velazquez Angeles, N.
    [J]. DRUG SAFETY, 2019, 42 (10) : 1222 - 1223
  • [2] Challenges in pharmacovigilance
    Dikshit, R. K.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 333 - 333
  • [3] Ongoing Challenges in Pharmacovigilance
    Gerald J. Dal Pan
    [J]. Drug Safety, 2014, 37 : 1 - 8
  • [4] Challenges of Pharmacovigilance in the Neonate
    Convertino, I.
    Sansone, A. Capogrosso
    Marino, A.
    Galiulo, M. T.
    [J]. DRUG SAFETY, 2016, 39 (10) : 1010 - 1010
  • [5] Ongoing Challenges in Pharmacovigilance
    Dal Pan, Gerald J.
    [J]. DRUG SAFETY, 2014, 37 (01) : 1 - 8
  • [6] Pharmacovigilance: The new challenges
    Bagheri, Haleh
    Laroche, Marie-Laure
    Montastruc, Jean-Louis
    [J]. THERAPIE, 2016, 71 (02): : 121 - 122
  • [7] Pharmacovigilance in pediatrics: Current challenges
    Neubert A.
    [J]. Pediatric Drugs, 2012, 14 (1) : 1 - 5
  • [8] Pharmacovigilance in Pediatrics Current Challenges
    Neubert, Antje
    [J]. PEDIATRIC DRUGS, 2012, 14 (01) : 1 - 5
  • [9] Challenges in the pharmacovigilance of oncolytic drugs
    Meyboom, RHB
    [J]. DRUG SAFETY, 2005, 28 (10) : 929 - 929